Women with amnestic mild cognitive impairment and early Alzheimer’s disease had lower levels of acetyl-L-carnitine and its ...

The team's goal is to define other biomarkers in the brain that track closely with Alzheimer's disease progression. If further studies confirm their latest findings, Nasca says the team's research ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

If further studies confirm their latest findings, Nasca says the team's research could be used to develop a blood test for dementia and for tracking the progression of Alzheimer's disease in an ...

“There are things that we can do at all stages of our lives deliberately,” says Prof Schott. “It’s never too early to start ...

The team’s goal is to define other biomarkers in the brain that track closely with Alzheimer’s disease progression. If further studies confirm their latest findings, Nasca says the team’s research ...

Betty Bigio. The Promise of a Noninvasive Blood Test Current methods for tracking Alzheimer’s involve spinal taps, which are invasive, painful, and carry risks. A blood test would offer a ...

A common cognitive disorder with symptoms that mimic Alzheimer's is often mistaken for the disease. Researchers are calling for criteria to diagnose the little-known condition.

Scientists working to cure Alzheimer's disease have found that menstrual blood could play a key role in treating the deadly ...

Roche and Eli Lilly have started testing a blood test that could be used to diagnose Alzheimer’s before symptoms arise, providing an alternative to expensive brain scans and speeding up the ...

The finding has implications for all of us, write Harvard physician-researchers Christopher Worsham and Anupam Jena.